Bulten UK Sector Assessment

Executive Summary

Purpose And Method

This paper follows two exercises already framed with Bulten: an opportunity model for where UK growth can come from outside the current book, and a growth model that turns those sector choices into Year 1 to Year 3 revenue. The research behind both ran the same chain: SIC codes for the addressable UK markets, the full company universe under those codes, grouping by sector, filings to size the buyers, a TAM built from filings and explicit assumptions, named accounts linked back to that TAM, then public evidence (including job specs and case material) on how fasteners are sold, who buys them, deal size and time to market. The figures below are planning inputs from that work, not a forecast of closed business.

Market Focus

Bulten should put industrial equipment first, and raise it from the smallest of the new-sector lines in the current plan to the largest. On research-validated planning inputs the sector produces about €830k of revenue in Year 1, €4.03m in Year 2 and €9.77m in Year 3. The workbook as it stands carries €750k, €1.25m and €2.50m for the same sector over the same three years. Every other new sector should sit behind it. Three of them should carry no organic revenue inside the three-year window.

The sector sequence reflects the work needed to turn an identified manufacturer into a paying customer. A large manufacturing business does not automatically offer an accessible fastener contract. Procurement arrangements, existing suppliers, product requirements and programme timetables determine whether Bulten can enter and how much of the account it can win. The assessment distinguishes an initial award from eventual annual account value, and a substantial plant contract from a multi-site agreement. Those differences matter more to the revenue plan than the number of companies carrying a particular industrial classification.

Agricultural mega-accounts (JCB and CNH-shaped) belong inside the industrial pursuit programme. Wind and rail should follow through limited trials. Defence requires an accreditation programme now, with restrained near-term revenue. Aerospace and medical should carry no organic revenue in Years 1 to 3 unless a named certification and programme path supports an exception.

The Seven Calls

Seven UK sectors were examined against a single test: how many real buyers exist, what a contract with one of them is worth, how long it lasts, and how long it takes to open.

• Industrial equipment and machinery: pursue now. This is the first diversification bet.
• Defence and security: start accreditation now. Sell later.
• Wind and energy: trial behind industrial.
• Rail rolling stock: trial behind industrial.
• Agricultural machinery: fold the mega-accounts into industrial and cut what remains.
• Aerospace and aviation: hold. No organic revenue before Year 4 without a named certification and programme path.
• Medical devices: hold. No organic revenue before Year 4.

Why Industrial Comes First

Four things separate industrial equipment from the rest at once. The buyer list is the deepest: a Companies House screen of active UK manufacturers assembling in repeat volume returns about 134 qualified accounts, of which fourteen sit at £250m of UK turnover or above. No other sector examined returns more than 22 qualified accounts. There is no multi-year entry gate: ISO 9001 is the quality baseline and Bulten Ltd, Scunthorpe already appears on the group Bureau Veritas certificate. It is the only new sector that can invoice inside twelve months on an organic path. Relationships last: managed supply is physical (containers on the line, sometimes staffed), so accounts are slow to win and slow to lose. An eight-year working tenure is the planning input here, against three years in the workbook.

Industrial buyers already purchase the service Bulten runs. Managed supply, kitting and line feeding for repeat-volume assembly is the Jaguar Land Rover book with a different customer name. Nothing new has to be built to sell into this sector. Named illustrations of the kinds of production businesses in scope include JCB, Cummins, Perkins, Komatsu and Terex. They are not interchangeable accounts. Initial supply may be a restricted range; mature value depends on expansion into further parts, lines or sites.

Evidence that the service is purchased establishes a market; it does not establish an open contract. CDE Global already uses Supply Technologies for Kanban supply and is a displacement prospect, not greenfield. The 134 buyers, the eight-year tenure and the €9.77m Year 3 industrial figure are planning inputs from a counted screen and a capacity-bound win schedule, not proven outcomes. The ranked buyer list and win schedule should accompany the working model.

Agricultural Machinery: Two Separate Moves

The agricultural line needs two corrections, different in kind. First, re-label: JCB and CNH-shaped accounts belong in the industrial pursuit programme. Their production requirements should not be represented by an average drawn from smaller UK agricultural manufacturers. Moving them changes the sector label; it does not by itself create revenue. Each opportunity should be counted once.

Second, cut what remains. After the mega-accounts move, the unique UK agricultural universe is about eight qualified buyers. Candidate annual contract value is €211k, with €74k in Year 2 and €358k in Year 3. The original agricultural Year 3 assumption was €20.00m; the industrial Year 3 rise is €7.27m. Relabelling cannot account for the whole reduction. Those two edits must stay separate in any board discussion.

Wind, Rail and Defence

Wind and rail should be tested behind industrial. Candidate annual contract values are €1.24m for wind and €983k for rail. Tenure for each should be five years, replacing the original fifteen-year wind and ten-year rail assumptions. Base timing to recurring revenue is fifteen months: no Year 1 revenue, initial contribution in Year 2. Trials should test whether Bulten can identify suitable components, meet requirements and obtain a place in procurement, without taking disproportionate attention from industrial.

Defence merits preparatory investment now with a restrained revenue assumption. The immediate work is JOSCAR and Cyber Essentials against named customer requirements. Candidate annual contract value is €1.67m; base time to recurring revenue is twenty-four months, with €586k in Year 3 and none before. The original €5.00m Year 3 line required faster or broader conversion than the schedule supports. Accreditation should start this quarter; selling follows validation of how primes actually buy managed C-parts supply.

Aerospace and Medical

Aerospace remains conditional. Candidate annual contract value is €1.64m, but certification and a named programme path must precede an organic revenue commitment. The schedule carries €0 in Years 1 to 3. Medical remains on hold: lower fastener intensity, longer qualification, and no organic revenue in the window. Neither sector should be used to fill a near-term gap that industrial sales have not yet closed.

What the Plan Totals

Across the seven sectors, candidate annual revenue totals are €830k, €4.88m and €13.72m for Years 1, 2 and 3. The original figures were €750k, €12.50m and €36.13m. The Year 3 reduction is €22.41m. Euro comparisons use £1 = €1.17 for research inputs built in pounds. Automotive and SRAM sit outside these sector totals.

Year 1 is close to the workbook. Years 2 and 3 are not. The Year 3 gap has two causes that should be handled separately: allocation (the plan bets largest on agricultural and smallest on industrial; the evidence supports the reverse) and timing (aerospace, defence and medical cannot produce the workbook's Year 3 organic revenue before entry gates are started).

All revenue figures are unweighted sales. They are not reduced for the chance of winning the work, and they are not reduced to gross profit. Flat lifetime value is annual contract value multiplied by tenure. Grown lifetime value includes an expansion allowance and should be shown separately whenever used. For operational planning, the annual schedule remains essential.

Commercial Investment

The growth programme requires a deliberate increase in commercial investment. Sales and marketing is currently under 1.5% of revenue, against a working target of 3 to 4%. The budget brief requires net EBITDA of about 14% to leave about 10% after that reinvestment. These are planning requirements for the detailed financial plan. No additional cost lines have been assumed in this assessment.

Increased effort should follow the sector sequence: industrial first; wind and rail trials limited; defence accreditation against named requirements; medical without an equivalent organic sales commitment while on hold. The industrial schedule is sensitive to delivery capacity because it assumes both new wins and expansion of accounts already secured. A target-account population is not a measure of how many accounts the sales organisation can pursue properly.

First-Year Review

The first twelve months should be managed as market-fit validation. Sales cycles are too long for meaningful conversion evidence across the programme before that point, even though an industrial account may begin invoicing earlier. The review should establish whether selected buyers recognise the proposed supply offer, whether its scope supports the assumed contract value, and whether a practical route to appointment exists.

Assumptions should be reviewed quarterly as live customer information arrives. Account size, timing and tenure should change when real part range, approval process or programme dates are known. Duplicate opportunities should be removed. Expansion inside an existing customer should be distinguished from a genuinely additional buying account.

Bulten should approve the sector sequence and use the candidate figures as the basis for the next growth-model revision, subject to the supporting account list and win schedule. Industrial carries the main organic diversification effort. Agricultural re-classification and the residual cut should be recorded separately. Wind and rail proceed through controlled trials. Defence qualification begins against identifiable requirements. Aerospace and medical revenue remain conditional.